Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Cash & Equivalents (2018 - 2025)

Dna X filings provide 8 years of Cash & Equivalents readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 75.61% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 75.61% decrease, with the full-year FY2025 number at $1.3 million, down 75.61% from a year prior.
  • Cash & Equivalents hit $1.3 million in Q4 2025 for Dna X, down from $2.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $13.9 million in Q1 2021 to a low of $101000.0 in Q1 2024.
  • Median Cash & Equivalents over the past 5 years was $2.1 million (2025), compared with a mean of $5.2 million.
  • Biggest five-year swings in Cash & Equivalents: tumbled 99.23% in 2023 and later surged 5138.24% in 2024.
  • Dna X's Cash & Equivalents stood at $11.2 million in 2021, then rose by 17.63% to $13.2 million in 2022, then tumbled by 99.23% to $102000.0 in 2023, then surged by 5138.24% to $5.3 million in 2024, then crashed by 75.61% to $1.3 million in 2025.
  • The last three reported values for Cash & Equivalents were $1.3 million (Q4 2025), $2.1 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.